EGFR exon 18 deletion
|
NSCLC
|
EGFR exon 18 deletion
|
NSCLC
|
osimertinib + MEDI9447 Sensitive: C3 – Early Trials
|
osimertinib + MEDI9447 Sensitive: C3 – Early Trials
|
EGFR exon 18 deletion
|
LUAD
|
EGFR exon 18 deletion
|
LUAD
|
afatinib Sensitive: C4 – Case Studies
|
afatinib Sensitive: C4 – Case Studies
|